Transcriptional inactivation of TP73 expression in oligodendroglial tumors

被引:53
作者
Dong, SM
Pang, JCS
Hu, J
Zhou, LF
Ng, HK [1 ]
机构
[1] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Anat & Cellular Pathol, Hong Kong, Hong Kong, Peoples R China
[2] Hua Shan Hosp, Dept Neurosurg, Shanghai, Peoples R China
关键词
oligodendroglioma; TP73; mutation; methylation; CpG islands;
D O I
10.1002/ijc.10204
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The TP73 gene, located on chromosome Ip36.3, encodes a product that shares significant structural homology with the tumor suppressor TP53. The aim of this study was to investigate whether TP73 is involved in the development of oligodendroglial tumors, which frequently carry deletions involving Ip36.3. Semi-quantitative reverse transcription-polymerase chain reaction was used to determine TP73 transcript levels. Ten of 24 (42%) tumors showed negligible to more than 5-fold reduction in TP73 expression when compared to normal brain level. To identify potential mechanisms that may modulate TP73 transcription in oligodendroglial tumors, we performed mutation analysis on the TP73 gene. No somatic mutations were however detected in the gene sequence. We then evaluated the possible involvement of epigenetic change in TP73 expression. Bisulfite genomic sequencing detected aberrant hypermethylation at the 5' region upstream and including the first exon of the TP73 gene in 17 of 44 (39%) oligodendroglial tumors, whereas normal brain tissues showed no methylation in the same region examined. Moreover, 6 of 10 (60%) tumors with negligible or decreased levels of TP73 transcripts were methylation-positive. In conclusion, our results showed that inactivation of TP73 occurs at the transcriptional level and is associated with promotor hypermethylation. Loss of or reduced TP73 transcript expression may contribute to the tumorigenesis of oligodendroglial tumors. (C) 2002 Wiley-Liss, Inc.
引用
收藏
页码:370 / 375
页数:6
相关论文
共 41 条
[1]   Loss of heterozygosity, allele silencing and decreased expression of p73 gene in breast cancers:: Prevalence of alterations in inflammatory breast cancers [J].
Ahomadegbe, JC ;
Tourpin, S ;
Kaghad, M ;
Zelek, L ;
Vayssade, M ;
Mathieu, MC ;
Rochard, F ;
Spielmann, M ;
Tursz, T ;
Caput, D ;
Riou, G ;
Bénard, J .
ONCOGENE, 2000, 19 (47) :5413-5418
[2]   Methylation-independent silencing of the p73 gene in neuroblastoma [J].
Banelli, B ;
Casciano, I ;
Romani, M .
ONCOGENE, 2000, 19 (39) :4553-4556
[3]  
BELLO MJ, 1995, INT J CANCER, V64, P207
[4]   Molecular genetic aspects of oligodendrogliomas including analysis by comparative genomic hybridization [J].
Bigner, SH ;
Matthews, MR ;
Rasheed, BKA ;
Wiltshire, RN ;
Friedman, HS ;
Friedman, AH ;
Stenzel, TT ;
Dawes, DM ;
McLendon, RE ;
Bigner, DD .
AMERICAN JOURNAL OF PATHOLOGY, 1999, 155 (02) :375-386
[5]   Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas [J].
Cairncross, JG ;
Ueki, K ;
Zlatescu, MC ;
Lisle, DK ;
Finkelstein, DM ;
Hammond, RR ;
Silver, JS ;
Stark, PC ;
Macdonald, DR ;
Ino, Y ;
Ramsay, DA ;
Louis, DN .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (19) :1473-1479
[6]  
Chen CL, 2000, CLIN CANCER RES, V6, P3910
[7]   Molecular analysis of microdissected de novo glioblastomas and paired astrocytic tumors [J].
Cheng, Y ;
Ng, HK ;
Ding, M ;
Zhang, SF ;
Pang, JCS ;
Lo, KW .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1999, 58 (02) :120-128
[8]  
CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990
[9]  
Corn PG, 1999, CANCER RES, V59, P3352
[10]  
Costello JF, 1996, CANCER RES, V56, P2405